Romano, Emanuela
Inserm · Université Paris Sciences et Lettres · Institut Curie
7 papers on CoChatORCID 0000-0002-1574-5545
Most cited papers
- Verified
Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients
Romano, E., Kusio-Kobialka, M., Foukas, P. G., Baumgaertner, P., Meyer, C., Ballabeni, P., Michielin, O., Weide, B., Romero, P., & Speiser, D. E. (2015) · Proceedings of the National Academy of Sciences
Cancer Immunotherapy and BiomarkersImmune cells in cancer
Cited by 601
- Verified
Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab
Weide, B., Martens, A., Hassel, J. C., Berking, C., Postow, M. A., Bisschop, K., Simeone, E., Mangana, J., Schilling, B., Di Giacomo, A. M., et al. (2016) · Clinical Cancer Research
Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management
Cited by 589
- Verified
Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab
Meyer, C., Cagnon, L., Costa-Nunes, C. M., Baumgaertner, P., Montandon, N., Leyvraz, L., Michielin, O., Romano, E., & Speiser, D. E. (2014) · Cancer Immunology Immunotherapy
Immune cells in cancerCancer Immunotherapy and Biomarkers
Cited by 560
- Verified
Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
Martens, A., Wistuba-Hamprecht, K., Foppen, M. G., Yuan, J., Postow, M. A., Wong, P., Romano, E., Khammari, A., Dreno, B., Capone, M., et al. (2016) · Clinical Cancer Research
Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management
Cited by 541
- Verified
Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study
Cabel, L., Riva, F., Servois, V., Livartowski, A., Daniel, C., Rampanou, A., Lantz, O., Romano, E., Milder, M., Buecher, B., et al. (2017) · Annals of Oncology
Cancer Immunotherapy and BiomarkersCancer Genomics and Diagnostics
Cited by 315
- Verified
Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients
Wistuba-Hamprecht, K., Martens, A., Heubach, F., Romano, E., Geukes Foppen, M., Yuan, J., Postow, M., Wong, P., Mallardo, D., Schilling, B., et al. (2017) · European Journal of Cancer
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 108
- Verified
At the Interface of Tumor-Associated Macrophages and Fibroblasts: Immune-Suppressive Networks and Emerging Exploitable Targets
Timperi, E., Croizer, H., Khantakova, D., Rana, M., Molgora, M., Guerriero, J. L., Mechta-Grigoriou, F., & Romano, E. (2024) · Clinical Cancer Research
Immune cells in cancerCancer Immunotherapy and Biomarkers
Cited by 49
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free